BOSTON, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, announced that Craig Thompson, chief ...
When comparing Clover Health Medicare Advantage to two other randomly chosen Medicare Advantage plans offered by large health ...
A short course of treatment with RNS60, as an add-on to riluzole, extended the survival of ALS patients by about six months, ...
On day 1 of the Family Heart Global Summit, speakers highlighted the critical need for awareness, early diagnosis, and ...
A UNIGE team has discovered the genetic programs that allow motor neurons to retract from the spinal cord. This discovery ...
Athira Pharma will cut about 49 positions, including two people in the C-suite. The announcement follows the company’s ...
Shares of Cosciens Biopharma fell Monday morning after it said it will discontinue research into its ALS treatment as management continues to lay off staff and cut costs across the company. Shares ...
About Pressurized Gas eXpanded Liquid Technology (PGX) ...
The following is a summary of “How to detect affect recognition alterations in amyotrophic lateral sclerosis,” published in the September 2024 issue of Neurology by Castelnovo et al. Researchers condu ...
BILLINGS — Hundreds gathered at ZooMontana for the first ever ALS walk in Billings, hoping to raise funds for research and ...
Originally proposed as the first Chicago River Swim in more than a century, the race was held in the lake after a late ...
The NFL admitted no wrongdoing, but agreed to fund a program that would pay retired players between $25,000 and $5 million if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback